Global Viral Gene Therapy Market Research Report 2024(Status and Outlook)
Report Overview
Gene therapy isthe treatment of a genetic disease by the introduction of specific cell function-altering genetic material into a patient. The key step in gene therapy is efficient gene delivery to the target tissue/cells, which is carried out by gene delivery vehicles called vectors.
This report provides a deep insight into the global Viral Gene Therapy market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Viral Gene Therapy Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Viral Gene Therapy market in any manner.
Global Viral Gene Therapy Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Lonza
Biogen
Catalent
Gilead Sciences
Sarepta Therapeutics
Novartis
Amgen
Ionis Pharmaceuticals
Spark Therapeutics
Shanghai Sunway Biotech
SIBIONO
AnGes
Orchard Therapeutics
Market Segmentation (by Type)
Integrating Viral Vectors
Non-Integrating Viral Vectors
Market Segmentation (by Application)
Metabolic Diseases
Cardiovascular Diseases
Muscular Diseases
Hematologic Diseases
Ophthalmologic Diseases
Infectious Diseases
Others
Geographic Segmentation
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Viral Gene Therapy Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
Gene therapy isthe treatment of a genetic disease by the introduction of specific cell function-altering genetic material into a patient. The key step in gene therapy is efficient gene delivery to the target tissue/cells, which is carried out by gene delivery vehicles called vectors.
This report provides a deep insight into the global Viral Gene Therapy market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Viral Gene Therapy Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Viral Gene Therapy market in any manner.
Global Viral Gene Therapy Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Lonza
Biogen
Catalent
Gilead Sciences
Sarepta Therapeutics
Novartis
Amgen
Ionis Pharmaceuticals
Spark Therapeutics
Shanghai Sunway Biotech
SIBIONO
AnGes
Orchard Therapeutics
Market Segmentation (by Type)
Integrating Viral Vectors
Non-Integrating Viral Vectors
Market Segmentation (by Application)
Metabolic Diseases
Cardiovascular Diseases
Muscular Diseases
Hematologic Diseases
Ophthalmologic Diseases
Infectious Diseases
Others
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the Viral Gene Therapy Market
- Overview of the regional outlook of the Viral Gene Therapy Market:
- Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
- This enables you to anticipate market changes to remain ahead of your competitors
- You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
- The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
- Provision of market value (USD Billion) data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- 6-month post-sales analyst support
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Viral Gene Therapy Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Viral Gene Therapy
1.2 Key Market Segments
1.2.1 Viral Gene Therapy Segment by Type
1.2.2 Viral Gene Therapy Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 VIRAL GENE THERAPY MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Viral Gene Therapy Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Viral Gene Therapy Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 VIRAL GENE THERAPY MARKET COMPETITIVE LANDSCAPE
3.1 Global Viral Gene Therapy Sales by Manufacturers (2019-2024)
3.2 Global Viral Gene Therapy Revenue Market Share by Manufacturers (2019-2024)
3.3 Viral Gene Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Viral Gene Therapy Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Viral Gene Therapy Sales Sites, Area Served, Product Type
3.6 Viral Gene Therapy Market Competitive Situation and Trends
3.6.1 Viral Gene Therapy Market Concentration Rate
3.6.2 Global 5 and 10 Largest Viral Gene Therapy Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 VIRAL GENE THERAPY INDUSTRY CHAIN ANALYSIS
4.1 Viral Gene Therapy Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF VIRAL GENE THERAPY MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 VIRAL GENE THERAPY MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Viral Gene Therapy Sales Market Share by Type (2019-2024)
6.3 Global Viral Gene Therapy Market Size Market Share by Type (2019-2024)
6.4 Global Viral Gene Therapy Price by Type (2019-2024)
7 VIRAL GENE THERAPY MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Viral Gene Therapy Market Sales by Application (2019-2024)
7.3 Global Viral Gene Therapy Market Size (M USD) by Application (2019-2024)
7.4 Global Viral Gene Therapy Sales Growth Rate by Application (2019-2024)
8 VIRAL GENE THERAPY MARKET SEGMENTATION BY REGION
8.1 Global Viral Gene Therapy Sales by Region
8.1.1 Global Viral Gene Therapy Sales by Region
8.1.2 Global Viral Gene Therapy Sales Market Share by Region
8.2 North America
8.2.1 North America Viral Gene Therapy Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Viral Gene Therapy Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Viral Gene Therapy Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Viral Gene Therapy Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Viral Gene Therapy Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 Lonza
9.1.1 Lonza Viral Gene Therapy Basic Information
9.1.2 Lonza Viral Gene Therapy Product Overview
9.1.3 Lonza Viral Gene Therapy Product Market Performance
9.1.4 Lonza Business Overview
9.1.5 Lonza Viral Gene Therapy SWOT Analysis
9.1.6 Lonza Recent Developments
9.2 Biogen
9.2.1 Biogen Viral Gene Therapy Basic Information
9.2.2 Biogen Viral Gene Therapy Product Overview
9.2.3 Biogen Viral Gene Therapy Product Market Performance
9.2.4 Biogen Business Overview
9.2.5 Biogen Viral Gene Therapy SWOT Analysis
9.2.6 Biogen Recent Developments
9.3 Catalent
9.3.1 Catalent Viral Gene Therapy Basic Information
9.3.2 Catalent Viral Gene Therapy Product Overview
9.3.3 Catalent Viral Gene Therapy Product Market Performance
9.3.4 Catalent Viral Gene Therapy SWOT Analysis
9.3.5 Catalent Business Overview
9.3.6 Catalent Recent Developments
9.4 Gilead Sciences
9.4.1 Gilead Sciences Viral Gene Therapy Basic Information
9.4.2 Gilead Sciences Viral Gene Therapy Product Overview
9.4.3 Gilead Sciences Viral Gene Therapy Product Market Performance
9.4.4 Gilead Sciences Business Overview
9.4.5 Gilead Sciences Recent Developments
9.5 Sarepta Therapeutics
9.5.1 Sarepta Therapeutics Viral Gene Therapy Basic Information
9.5.2 Sarepta Therapeutics Viral Gene Therapy Product Overview
9.5.3 Sarepta Therapeutics Viral Gene Therapy Product Market Performance
9.5.4 Sarepta Therapeutics Business Overview
9.5.5 Sarepta Therapeutics Recent Developments
9.6 Novartis
9.6.1 Novartis Viral Gene Therapy Basic Information
9.6.2 Novartis Viral Gene Therapy Product Overview
9.6.3 Novartis Viral Gene Therapy Product Market Performance
9.6.4 Novartis Business Overview
9.6.5 Novartis Recent Developments
9.7 Amgen
9.7.1 Amgen Viral Gene Therapy Basic Information
9.7.2 Amgen Viral Gene Therapy Product Overview
9.7.3 Amgen Viral Gene Therapy Product Market Performance
9.7.4 Amgen Business Overview
9.7.5 Amgen Recent Developments
9.8 Ionis Pharmaceuticals
9.8.1 Ionis Pharmaceuticals Viral Gene Therapy Basic Information
9.8.2 Ionis Pharmaceuticals Viral Gene Therapy Product Overview
9.8.3 Ionis Pharmaceuticals Viral Gene Therapy Product Market Performance
9.8.4 Ionis Pharmaceuticals Business Overview
9.8.5 Ionis Pharmaceuticals Recent Developments
9.9 Spark Therapeutics
9.9.1 Spark Therapeutics Viral Gene Therapy Basic Information
9.9.2 Spark Therapeutics Viral Gene Therapy Product Overview
9.9.3 Spark Therapeutics Viral Gene Therapy Product Market Performance
9.9.4 Spark Therapeutics Business Overview
9.9.5 Spark Therapeutics Recent Developments
9.10 Shanghai Sunway Biotech
9.10.1 Shanghai Sunway Biotech Viral Gene Therapy Basic Information
9.10.2 Shanghai Sunway Biotech Viral Gene Therapy Product Overview
9.10.3 Shanghai Sunway Biotech Viral Gene Therapy Product Market Performance
9.10.4 Shanghai Sunway Biotech Business Overview
9.10.5 Shanghai Sunway Biotech Recent Developments
9.11 SIBIONO
9.11.1 SIBIONO Viral Gene Therapy Basic Information
9.11.2 SIBIONO Viral Gene Therapy Product Overview
9.11.3 SIBIONO Viral Gene Therapy Product Market Performance
9.11.4 SIBIONO Business Overview
9.11.5 SIBIONO Recent Developments
9.12 AnGes
9.12.1 AnGes Viral Gene Therapy Basic Information
9.12.2 AnGes Viral Gene Therapy Product Overview
9.12.3 AnGes Viral Gene Therapy Product Market Performance
9.12.4 AnGes Business Overview
9.12.5 AnGes Recent Developments
9.13 Orchard Therapeutics
9.13.1 Orchard Therapeutics Viral Gene Therapy Basic Information
9.13.2 Orchard Therapeutics Viral Gene Therapy Product Overview
9.13.3 Orchard Therapeutics Viral Gene Therapy Product Market Performance
9.13.4 Orchard Therapeutics Business Overview
9.13.5 Orchard Therapeutics Recent Developments
10 VIRAL GENE THERAPY MARKET FORECAST BY REGION
10.1 Global Viral Gene Therapy Market Size Forecast
10.2 Global Viral Gene Therapy Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Viral Gene Therapy Market Size Forecast by Country
10.2.3 Asia Pacific Viral Gene Therapy Market Size Forecast by Region
10.2.4 South America Viral Gene Therapy Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Viral Gene Therapy by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global Viral Gene Therapy Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Viral Gene Therapy by Type (2025-2030)
11.1.2 Global Viral Gene Therapy Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Viral Gene Therapy by Type (2025-2030)
11.2 Global Viral Gene Therapy Market Forecast by Application (2025-2030)
11.2.1 Global Viral Gene Therapy Sales (Kilotons) Forecast by Application
11.2.2 Global Viral Gene Therapy Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Viral Gene Therapy
1.2 Key Market Segments
1.2.1 Viral Gene Therapy Segment by Type
1.2.2 Viral Gene Therapy Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 VIRAL GENE THERAPY MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Viral Gene Therapy Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Viral Gene Therapy Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 VIRAL GENE THERAPY MARKET COMPETITIVE LANDSCAPE
3.1 Global Viral Gene Therapy Sales by Manufacturers (2019-2024)
3.2 Global Viral Gene Therapy Revenue Market Share by Manufacturers (2019-2024)
3.3 Viral Gene Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Viral Gene Therapy Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Viral Gene Therapy Sales Sites, Area Served, Product Type
3.6 Viral Gene Therapy Market Competitive Situation and Trends
3.6.1 Viral Gene Therapy Market Concentration Rate
3.6.2 Global 5 and 10 Largest Viral Gene Therapy Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 VIRAL GENE THERAPY INDUSTRY CHAIN ANALYSIS
4.1 Viral Gene Therapy Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF VIRAL GENE THERAPY MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 VIRAL GENE THERAPY MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Viral Gene Therapy Sales Market Share by Type (2019-2024)
6.3 Global Viral Gene Therapy Market Size Market Share by Type (2019-2024)
6.4 Global Viral Gene Therapy Price by Type (2019-2024)
7 VIRAL GENE THERAPY MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Viral Gene Therapy Market Sales by Application (2019-2024)
7.3 Global Viral Gene Therapy Market Size (M USD) by Application (2019-2024)
7.4 Global Viral Gene Therapy Sales Growth Rate by Application (2019-2024)
8 VIRAL GENE THERAPY MARKET SEGMENTATION BY REGION
8.1 Global Viral Gene Therapy Sales by Region
8.1.1 Global Viral Gene Therapy Sales by Region
8.1.2 Global Viral Gene Therapy Sales Market Share by Region
8.2 North America
8.2.1 North America Viral Gene Therapy Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Viral Gene Therapy Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Viral Gene Therapy Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Viral Gene Therapy Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Viral Gene Therapy Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 Lonza
9.1.1 Lonza Viral Gene Therapy Basic Information
9.1.2 Lonza Viral Gene Therapy Product Overview
9.1.3 Lonza Viral Gene Therapy Product Market Performance
9.1.4 Lonza Business Overview
9.1.5 Lonza Viral Gene Therapy SWOT Analysis
9.1.6 Lonza Recent Developments
9.2 Biogen
9.2.1 Biogen Viral Gene Therapy Basic Information
9.2.2 Biogen Viral Gene Therapy Product Overview
9.2.3 Biogen Viral Gene Therapy Product Market Performance
9.2.4 Biogen Business Overview
9.2.5 Biogen Viral Gene Therapy SWOT Analysis
9.2.6 Biogen Recent Developments
9.3 Catalent
9.3.1 Catalent Viral Gene Therapy Basic Information
9.3.2 Catalent Viral Gene Therapy Product Overview
9.3.3 Catalent Viral Gene Therapy Product Market Performance
9.3.4 Catalent Viral Gene Therapy SWOT Analysis
9.3.5 Catalent Business Overview
9.3.6 Catalent Recent Developments
9.4 Gilead Sciences
9.4.1 Gilead Sciences Viral Gene Therapy Basic Information
9.4.2 Gilead Sciences Viral Gene Therapy Product Overview
9.4.3 Gilead Sciences Viral Gene Therapy Product Market Performance
9.4.4 Gilead Sciences Business Overview
9.4.5 Gilead Sciences Recent Developments
9.5 Sarepta Therapeutics
9.5.1 Sarepta Therapeutics Viral Gene Therapy Basic Information
9.5.2 Sarepta Therapeutics Viral Gene Therapy Product Overview
9.5.3 Sarepta Therapeutics Viral Gene Therapy Product Market Performance
9.5.4 Sarepta Therapeutics Business Overview
9.5.5 Sarepta Therapeutics Recent Developments
9.6 Novartis
9.6.1 Novartis Viral Gene Therapy Basic Information
9.6.2 Novartis Viral Gene Therapy Product Overview
9.6.3 Novartis Viral Gene Therapy Product Market Performance
9.6.4 Novartis Business Overview
9.6.5 Novartis Recent Developments
9.7 Amgen
9.7.1 Amgen Viral Gene Therapy Basic Information
9.7.2 Amgen Viral Gene Therapy Product Overview
9.7.3 Amgen Viral Gene Therapy Product Market Performance
9.7.4 Amgen Business Overview
9.7.5 Amgen Recent Developments
9.8 Ionis Pharmaceuticals
9.8.1 Ionis Pharmaceuticals Viral Gene Therapy Basic Information
9.8.2 Ionis Pharmaceuticals Viral Gene Therapy Product Overview
9.8.3 Ionis Pharmaceuticals Viral Gene Therapy Product Market Performance
9.8.4 Ionis Pharmaceuticals Business Overview
9.8.5 Ionis Pharmaceuticals Recent Developments
9.9 Spark Therapeutics
9.9.1 Spark Therapeutics Viral Gene Therapy Basic Information
9.9.2 Spark Therapeutics Viral Gene Therapy Product Overview
9.9.3 Spark Therapeutics Viral Gene Therapy Product Market Performance
9.9.4 Spark Therapeutics Business Overview
9.9.5 Spark Therapeutics Recent Developments
9.10 Shanghai Sunway Biotech
9.10.1 Shanghai Sunway Biotech Viral Gene Therapy Basic Information
9.10.2 Shanghai Sunway Biotech Viral Gene Therapy Product Overview
9.10.3 Shanghai Sunway Biotech Viral Gene Therapy Product Market Performance
9.10.4 Shanghai Sunway Biotech Business Overview
9.10.5 Shanghai Sunway Biotech Recent Developments
9.11 SIBIONO
9.11.1 SIBIONO Viral Gene Therapy Basic Information
9.11.2 SIBIONO Viral Gene Therapy Product Overview
9.11.3 SIBIONO Viral Gene Therapy Product Market Performance
9.11.4 SIBIONO Business Overview
9.11.5 SIBIONO Recent Developments
9.12 AnGes
9.12.1 AnGes Viral Gene Therapy Basic Information
9.12.2 AnGes Viral Gene Therapy Product Overview
9.12.3 AnGes Viral Gene Therapy Product Market Performance
9.12.4 AnGes Business Overview
9.12.5 AnGes Recent Developments
9.13 Orchard Therapeutics
9.13.1 Orchard Therapeutics Viral Gene Therapy Basic Information
9.13.2 Orchard Therapeutics Viral Gene Therapy Product Overview
9.13.3 Orchard Therapeutics Viral Gene Therapy Product Market Performance
9.13.4 Orchard Therapeutics Business Overview
9.13.5 Orchard Therapeutics Recent Developments
10 VIRAL GENE THERAPY MARKET FORECAST BY REGION
10.1 Global Viral Gene Therapy Market Size Forecast
10.2 Global Viral Gene Therapy Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Viral Gene Therapy Market Size Forecast by Country
10.2.3 Asia Pacific Viral Gene Therapy Market Size Forecast by Region
10.2.4 South America Viral Gene Therapy Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Viral Gene Therapy by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global Viral Gene Therapy Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Viral Gene Therapy by Type (2025-2030)
11.1.2 Global Viral Gene Therapy Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Viral Gene Therapy by Type (2025-2030)
11.2 Global Viral Gene Therapy Market Forecast by Application (2025-2030)
11.2.1 Global Viral Gene Therapy Sales (Kilotons) Forecast by Application
11.2.2 Global Viral Gene Therapy Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Viral Gene Therapy Market Size Comparison by Region (M USD)
Table 5. Global Viral Gene Therapy Sales (Kilotons) by Manufacturers (2019-2024)
Table 6. Global Viral Gene Therapy Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Viral Gene Therapy Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Viral Gene Therapy Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Viral Gene Therapy as of 2022)
Table 10. Global Market Viral Gene Therapy Average Price (USD/Ton) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Viral Gene Therapy Sales Sites and Area Served
Table 12. Manufacturers Viral Gene Therapy Product Type
Table 13. Global Viral Gene Therapy Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Viral Gene Therapy
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Viral Gene Therapy Market Challenges
Table 22. Global Viral Gene Therapy Sales by Type (Kilotons)
Table 23. Global Viral Gene Therapy Market Size by Type (M USD)
Table 24. Global Viral Gene Therapy Sales (Kilotons) by Type (2019-2024)
Table 25. Global Viral Gene Therapy Sales Market Share by Type (2019-2024)
Table 26. Global Viral Gene Therapy Market Size (M USD) by Type (2019-2024)
Table 27. Global Viral Gene Therapy Market Size Share by Type (2019-2024)
Table 28. Global Viral Gene Therapy Price (USD/Ton) by Type (2019-2024)
Table 29. Global Viral Gene Therapy Sales (Kilotons) by Application
Table 30. Global Viral Gene Therapy Market Size by Application
Table 31. Global Viral Gene Therapy Sales by Application (2019-2024) & (Kilotons)
Table 32. Global Viral Gene Therapy Sales Market Share by Application (2019-2024)
Table 33. Global Viral Gene Therapy Sales by Application (2019-2024) & (M USD)
Table 34. Global Viral Gene Therapy Market Share by Application (2019-2024)
Table 35. Global Viral Gene Therapy Sales Growth Rate by Application (2019-2024)
Table 36. Global Viral Gene Therapy Sales by Region (2019-2024) & (Kilotons)
Table 37. Global Viral Gene Therapy Sales Market Share by Region (2019-2024)
Table 38. North America Viral Gene Therapy Sales by Country (2019-2024) & (Kilotons)
Table 39. Europe Viral Gene Therapy Sales by Country (2019-2024) & (Kilotons)
Table 40. Asia Pacific Viral Gene Therapy Sales by Region (2019-2024) & (Kilotons)
Table 41. South America Viral Gene Therapy Sales by Country (2019-2024) & (Kilotons)
Table 42. Middle East and Africa Viral Gene Therapy Sales by Region (2019-2024) & (Kilotons)
Table 43. Lonza Viral Gene Therapy Basic Information
Table 44. Lonza Viral Gene Therapy Product Overview
Table 45. Lonza Viral Gene Therapy Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 46. Lonza Business Overview
Table 47. Lonza Viral Gene Therapy SWOT Analysis
Table 48. Lonza Recent Developments
Table 49. Biogen Viral Gene Therapy Basic Information
Table 50. Biogen Viral Gene Therapy Product Overview
Table 51. Biogen Viral Gene Therapy Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 52. Biogen Business Overview
Table 53. Biogen Viral Gene Therapy SWOT Analysis
Table 54. Biogen Recent Developments
Table 55. Catalent Viral Gene Therapy Basic Information
Table 56. Catalent Viral Gene Therapy Product Overview
Table 57. Catalent Viral Gene Therapy Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 58. Catalent Viral Gene Therapy SWOT Analysis
Table 59. Catalent Business Overview
Table 60. Catalent Recent Developments
Table 61. Gilead Sciences Viral Gene Therapy Basic Information
Table 62. Gilead Sciences Viral Gene Therapy Product Overview
Table 63. Gilead Sciences Viral Gene Therapy Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 64. Gilead Sciences Business Overview
Table 65. Gilead Sciences Recent Developments
Table 66. Sarepta Therapeutics Viral Gene Therapy Basic Information
Table 67. Sarepta Therapeutics Viral Gene Therapy Product Overview
Table 68. Sarepta Therapeutics Viral Gene Therapy Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 69. Sarepta Therapeutics Business Overview
Table 70. Sarepta Therapeutics Recent Developments
Table 71. Novartis Viral Gene Therapy Basic Information
Table 72. Novartis Viral Gene Therapy Product Overview
Table 73. Novartis Viral Gene Therapy Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 74. Novartis Business Overview
Table 75. Novartis Recent Developments
Table 76. Amgen Viral Gene Therapy Basic Information
Table 77. Amgen Viral Gene Therapy Product Overview
Table 78. Amgen Viral Gene Therapy Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 79. Amgen Business Overview
Table 80. Amgen Recent Developments
Table 81. Ionis Pharmaceuticals Viral Gene Therapy Basic Information
Table 82. Ionis Pharmaceuticals Viral Gene Therapy Product Overview
Table 83. Ionis Pharmaceuticals Viral Gene Therapy Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 84. Ionis Pharmaceuticals Business Overview
Table 85. Ionis Pharmaceuticals Recent Developments
Table 86. Spark Therapeutics Viral Gene Therapy Basic Information
Table 87. Spark Therapeutics Viral Gene Therapy Product Overview
Table 88. Spark Therapeutics Viral Gene Therapy Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 89. Spark Therapeutics Business Overview
Table 90. Spark Therapeutics Recent Developments
Table 91. Shanghai Sunway Biotech Viral Gene Therapy Basic Information
Table 92. Shanghai Sunway Biotech Viral Gene Therapy Product Overview
Table 93. Shanghai Sunway Biotech Viral Gene Therapy Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 94. Shanghai Sunway Biotech Business Overview
Table 95. Shanghai Sunway Biotech Recent Developments
Table 96. SIBIONO Viral Gene Therapy Basic Information
Table 97. SIBIONO Viral Gene Therapy Product Overview
Table 98. SIBIONO Viral Gene Therapy Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 99. SIBIONO Business Overview
Table 100. SIBIONO Recent Developments
Table 101. AnGes Viral Gene Therapy Basic Information
Table 102. AnGes Viral Gene Therapy Product Overview
Table 103. AnGes Viral Gene Therapy Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 104. AnGes Business Overview
Table 105. AnGes Recent Developments
Table 106. Orchard Therapeutics Viral Gene Therapy Basic Information
Table 107. Orchard Therapeutics Viral Gene Therapy Product Overview
Table 108. Orchard Therapeutics Viral Gene Therapy Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 109. Orchard Therapeutics Business Overview
Table 110. Orchard Therapeutics Recent Developments
Table 111. Global Viral Gene Therapy Sales Forecast by Region (2025-2030) & (Kilotons)
Table 112. Global Viral Gene Therapy Market Size Forecast by Region (2025-2030) & (M USD)
Table 113. North America Viral Gene Therapy Sales Forecast by Country (2025-2030) & (Kilotons)
Table 114. North America Viral Gene Therapy Market Size Forecast by Country (2025-2030) & (M USD)
Table 115. Europe Viral Gene Therapy Sales Forecast by Country (2025-2030) & (Kilotons)
Table 116. Europe Viral Gene Therapy Market Size Forecast by Country (2025-2030) & (M USD)
Table 117. Asia Pacific Viral Gene Therapy Sales Forecast by Region (2025-2030) & (Kilotons)
Table 118. Asia Pacific Viral Gene Therapy Market Size Forecast by Region (2025-2030) & (M USD)
Table 119. South America Viral Gene Therapy Sales Forecast by Country (2025-2030) & (Kilotons)
Table 120. South America Viral Gene Therapy Market Size Forecast by Country (2025-2030) & (M USD)
Table 121. Middle East and Africa Viral Gene Therapy Consumption Forecast by Country (2025-2030) & (Units)
Table 122. Middle East and Africa Viral Gene Therapy Market Size Forecast by Country (2025-2030) & (M USD)
Table 123. Global Viral Gene Therapy Sales Forecast by Type (2025-2030) & (Kilotons)
Table 124. Global Viral Gene Therapy Market Size Forecast by Type (2025-2030) & (M USD)
Table 125. Global Viral Gene Therapy Price Forecast by Type (2025-2030) & (USD/Ton)
Table 126. Global Viral Gene Therapy Sales (Kilotons) Forecast by Application (2025-2030)
Table 127. Global Viral Gene Therapy Market Size Forecast by Application (2025-2030) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Viral Gene Therapy Market Size Comparison by Region (M USD)
Table 5. Global Viral Gene Therapy Sales (Kilotons) by Manufacturers (2019-2024)
Table 6. Global Viral Gene Therapy Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Viral Gene Therapy Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Viral Gene Therapy Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Viral Gene Therapy as of 2022)
Table 10. Global Market Viral Gene Therapy Average Price (USD/Ton) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Viral Gene Therapy Sales Sites and Area Served
Table 12. Manufacturers Viral Gene Therapy Product Type
Table 13. Global Viral Gene Therapy Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Viral Gene Therapy
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Viral Gene Therapy Market Challenges
Table 22. Global Viral Gene Therapy Sales by Type (Kilotons)
Table 23. Global Viral Gene Therapy Market Size by Type (M USD)
Table 24. Global Viral Gene Therapy Sales (Kilotons) by Type (2019-2024)
Table 25. Global Viral Gene Therapy Sales Market Share by Type (2019-2024)
Table 26. Global Viral Gene Therapy Market Size (M USD) by Type (2019-2024)
Table 27. Global Viral Gene Therapy Market Size Share by Type (2019-2024)
Table 28. Global Viral Gene Therapy Price (USD/Ton) by Type (2019-2024)
Table 29. Global Viral Gene Therapy Sales (Kilotons) by Application
Table 30. Global Viral Gene Therapy Market Size by Application
Table 31. Global Viral Gene Therapy Sales by Application (2019-2024) & (Kilotons)
Table 32. Global Viral Gene Therapy Sales Market Share by Application (2019-2024)
Table 33. Global Viral Gene Therapy Sales by Application (2019-2024) & (M USD)
Table 34. Global Viral Gene Therapy Market Share by Application (2019-2024)
Table 35. Global Viral Gene Therapy Sales Growth Rate by Application (2019-2024)
Table 36. Global Viral Gene Therapy Sales by Region (2019-2024) & (Kilotons)
Table 37. Global Viral Gene Therapy Sales Market Share by Region (2019-2024)
Table 38. North America Viral Gene Therapy Sales by Country (2019-2024) & (Kilotons)
Table 39. Europe Viral Gene Therapy Sales by Country (2019-2024) & (Kilotons)
Table 40. Asia Pacific Viral Gene Therapy Sales by Region (2019-2024) & (Kilotons)
Table 41. South America Viral Gene Therapy Sales by Country (2019-2024) & (Kilotons)
Table 42. Middle East and Africa Viral Gene Therapy Sales by Region (2019-2024) & (Kilotons)
Table 43. Lonza Viral Gene Therapy Basic Information
Table 44. Lonza Viral Gene Therapy Product Overview
Table 45. Lonza Viral Gene Therapy Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 46. Lonza Business Overview
Table 47. Lonza Viral Gene Therapy SWOT Analysis
Table 48. Lonza Recent Developments
Table 49. Biogen Viral Gene Therapy Basic Information
Table 50. Biogen Viral Gene Therapy Product Overview
Table 51. Biogen Viral Gene Therapy Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 52. Biogen Business Overview
Table 53. Biogen Viral Gene Therapy SWOT Analysis
Table 54. Biogen Recent Developments
Table 55. Catalent Viral Gene Therapy Basic Information
Table 56. Catalent Viral Gene Therapy Product Overview
Table 57. Catalent Viral Gene Therapy Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 58. Catalent Viral Gene Therapy SWOT Analysis
Table 59. Catalent Business Overview
Table 60. Catalent Recent Developments
Table 61. Gilead Sciences Viral Gene Therapy Basic Information
Table 62. Gilead Sciences Viral Gene Therapy Product Overview
Table 63. Gilead Sciences Viral Gene Therapy Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 64. Gilead Sciences Business Overview
Table 65. Gilead Sciences Recent Developments
Table 66. Sarepta Therapeutics Viral Gene Therapy Basic Information
Table 67. Sarepta Therapeutics Viral Gene Therapy Product Overview
Table 68. Sarepta Therapeutics Viral Gene Therapy Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 69. Sarepta Therapeutics Business Overview
Table 70. Sarepta Therapeutics Recent Developments
Table 71. Novartis Viral Gene Therapy Basic Information
Table 72. Novartis Viral Gene Therapy Product Overview
Table 73. Novartis Viral Gene Therapy Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 74. Novartis Business Overview
Table 75. Novartis Recent Developments
Table 76. Amgen Viral Gene Therapy Basic Information
Table 77. Amgen Viral Gene Therapy Product Overview
Table 78. Amgen Viral Gene Therapy Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 79. Amgen Business Overview
Table 80. Amgen Recent Developments
Table 81. Ionis Pharmaceuticals Viral Gene Therapy Basic Information
Table 82. Ionis Pharmaceuticals Viral Gene Therapy Product Overview
Table 83. Ionis Pharmaceuticals Viral Gene Therapy Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 84. Ionis Pharmaceuticals Business Overview
Table 85. Ionis Pharmaceuticals Recent Developments
Table 86. Spark Therapeutics Viral Gene Therapy Basic Information
Table 87. Spark Therapeutics Viral Gene Therapy Product Overview
Table 88. Spark Therapeutics Viral Gene Therapy Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 89. Spark Therapeutics Business Overview
Table 90. Spark Therapeutics Recent Developments
Table 91. Shanghai Sunway Biotech Viral Gene Therapy Basic Information
Table 92. Shanghai Sunway Biotech Viral Gene Therapy Product Overview
Table 93. Shanghai Sunway Biotech Viral Gene Therapy Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 94. Shanghai Sunway Biotech Business Overview
Table 95. Shanghai Sunway Biotech Recent Developments
Table 96. SIBIONO Viral Gene Therapy Basic Information
Table 97. SIBIONO Viral Gene Therapy Product Overview
Table 98. SIBIONO Viral Gene Therapy Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 99. SIBIONO Business Overview
Table 100. SIBIONO Recent Developments
Table 101. AnGes Viral Gene Therapy Basic Information
Table 102. AnGes Viral Gene Therapy Product Overview
Table 103. AnGes Viral Gene Therapy Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 104. AnGes Business Overview
Table 105. AnGes Recent Developments
Table 106. Orchard Therapeutics Viral Gene Therapy Basic Information
Table 107. Orchard Therapeutics Viral Gene Therapy Product Overview
Table 108. Orchard Therapeutics Viral Gene Therapy Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 109. Orchard Therapeutics Business Overview
Table 110. Orchard Therapeutics Recent Developments
Table 111. Global Viral Gene Therapy Sales Forecast by Region (2025-2030) & (Kilotons)
Table 112. Global Viral Gene Therapy Market Size Forecast by Region (2025-2030) & (M USD)
Table 113. North America Viral Gene Therapy Sales Forecast by Country (2025-2030) & (Kilotons)
Table 114. North America Viral Gene Therapy Market Size Forecast by Country (2025-2030) & (M USD)
Table 115. Europe Viral Gene Therapy Sales Forecast by Country (2025-2030) & (Kilotons)
Table 116. Europe Viral Gene Therapy Market Size Forecast by Country (2025-2030) & (M USD)
Table 117. Asia Pacific Viral Gene Therapy Sales Forecast by Region (2025-2030) & (Kilotons)
Table 118. Asia Pacific Viral Gene Therapy Market Size Forecast by Region (2025-2030) & (M USD)
Table 119. South America Viral Gene Therapy Sales Forecast by Country (2025-2030) & (Kilotons)
Table 120. South America Viral Gene Therapy Market Size Forecast by Country (2025-2030) & (M USD)
Table 121. Middle East and Africa Viral Gene Therapy Consumption Forecast by Country (2025-2030) & (Units)
Table 122. Middle East and Africa Viral Gene Therapy Market Size Forecast by Country (2025-2030) & (M USD)
Table 123. Global Viral Gene Therapy Sales Forecast by Type (2025-2030) & (Kilotons)
Table 124. Global Viral Gene Therapy Market Size Forecast by Type (2025-2030) & (M USD)
Table 125. Global Viral Gene Therapy Price Forecast by Type (2025-2030) & (USD/Ton)
Table 126. Global Viral Gene Therapy Sales (Kilotons) Forecast by Application (2025-2030)
Table 127. Global Viral Gene Therapy Market Size Forecast by Application (2025-2030) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Viral Gene Therapy
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Viral Gene Therapy Market Size (M USD), 2019-2030
Figure 5. Global Viral Gene Therapy Market Size (M USD) (2019-2030)
Figure 6. Global Viral Gene Therapy Sales (Kilotons) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Viral Gene Therapy Market Size by Country (M USD)
Figure 11. Viral Gene Therapy Sales Share by Manufacturers in 2023
Figure 12. Global Viral Gene Therapy Revenue Share by Manufacturers in 2023
Figure 13. Viral Gene Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Viral Gene Therapy Average Price (USD/Ton) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Viral Gene Therapy Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Viral Gene Therapy Market Share by Type
Figure 18. Sales Market Share of Viral Gene Therapy by Type (2019-2024)
Figure 19. Sales Market Share of Viral Gene Therapy by Type in 2023
Figure 20. Market Size Share of Viral Gene Therapy by Type (2019-2024)
Figure 21. Market Size Market Share of Viral Gene Therapy by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Viral Gene Therapy Market Share by Application
Figure 24. Global Viral Gene Therapy Sales Market Share by Application (2019-2024)
Figure 25. Global Viral Gene Therapy Sales Market Share by Application in 2023
Figure 26. Global Viral Gene Therapy Market Share by Application (2019-2024)
Figure 27. Global Viral Gene Therapy Market Share by Application in 2023
Figure 28. Global Viral Gene Therapy Sales Growth Rate by Application (2019-2024)
Figure 29. Global Viral Gene Therapy Sales Market Share by Region (2019-2024)
Figure 30. North America Viral Gene Therapy Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 31. North America Viral Gene Therapy Sales Market Share by Country in 2023
Figure 32. U.S. Viral Gene Therapy Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 33. Canada Viral Gene Therapy Sales (Kilotons) and Growth Rate (2019-2024)
Figure 34. Mexico Viral Gene Therapy Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Viral Gene Therapy Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 36. Europe Viral Gene Therapy Sales Market Share by Country in 2023
Figure 37. Germany Viral Gene Therapy Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 38. France Viral Gene Therapy Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 39. U.K. Viral Gene Therapy Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 40. Italy Viral Gene Therapy Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 41. Russia Viral Gene Therapy Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 42. Asia Pacific Viral Gene Therapy Sales and Growth Rate (Kilotons)
Figure 43. Asia Pacific Viral Gene Therapy Sales Market Share by Region in 2023
Figure 44. China Viral Gene Therapy Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 45. Japan Viral Gene Therapy Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 46. South Korea Viral Gene Therapy Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 47. India Viral Gene Therapy Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 48. Southeast Asia Viral Gene Therapy Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 49. South America Viral Gene Therapy Sales and Growth Rate (Kilotons)
Figure 50. South America Viral Gene Therapy Sales Market Share by Country in 2023
Figure 51. Brazil Viral Gene Therapy Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 52. Argentina Viral Gene Therapy Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 53. Columbia Viral Gene Therapy Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 54. Middle East and Africa Viral Gene Therapy Sales and Growth Rate (Kilotons)
Figure 55. Middle East and Africa Viral Gene Therapy Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Viral Gene Therapy Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 57. UAE Viral Gene Therapy Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 58. Egypt Viral Gene Therapy Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 59. Nigeria Viral Gene Therapy Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 60. South Africa Viral Gene Therapy Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 61. Global Viral Gene Therapy Sales Forecast by Volume (2019-2030) & (Kilotons)
Figure 62. Global Viral Gene Therapy Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Viral Gene Therapy Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Viral Gene Therapy Market Share Forecast by Type (2025-2030)
Figure 65. Global Viral Gene Therapy Sales Forecast by Application (2025-2030)
Figure 66. Global Viral Gene Therapy Market Share Forecast by Application (2025-2030)
Figure 1. Product Picture of Viral Gene Therapy
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Viral Gene Therapy Market Size (M USD), 2019-2030
Figure 5. Global Viral Gene Therapy Market Size (M USD) (2019-2030)
Figure 6. Global Viral Gene Therapy Sales (Kilotons) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Viral Gene Therapy Market Size by Country (M USD)
Figure 11. Viral Gene Therapy Sales Share by Manufacturers in 2023
Figure 12. Global Viral Gene Therapy Revenue Share by Manufacturers in 2023
Figure 13. Viral Gene Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Viral Gene Therapy Average Price (USD/Ton) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Viral Gene Therapy Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Viral Gene Therapy Market Share by Type
Figure 18. Sales Market Share of Viral Gene Therapy by Type (2019-2024)
Figure 19. Sales Market Share of Viral Gene Therapy by Type in 2023
Figure 20. Market Size Share of Viral Gene Therapy by Type (2019-2024)
Figure 21. Market Size Market Share of Viral Gene Therapy by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Viral Gene Therapy Market Share by Application
Figure 24. Global Viral Gene Therapy Sales Market Share by Application (2019-2024)
Figure 25. Global Viral Gene Therapy Sales Market Share by Application in 2023
Figure 26. Global Viral Gene Therapy Market Share by Application (2019-2024)
Figure 27. Global Viral Gene Therapy Market Share by Application in 2023
Figure 28. Global Viral Gene Therapy Sales Growth Rate by Application (2019-2024)
Figure 29. Global Viral Gene Therapy Sales Market Share by Region (2019-2024)
Figure 30. North America Viral Gene Therapy Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 31. North America Viral Gene Therapy Sales Market Share by Country in 2023
Figure 32. U.S. Viral Gene Therapy Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 33. Canada Viral Gene Therapy Sales (Kilotons) and Growth Rate (2019-2024)
Figure 34. Mexico Viral Gene Therapy Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Viral Gene Therapy Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 36. Europe Viral Gene Therapy Sales Market Share by Country in 2023
Figure 37. Germany Viral Gene Therapy Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 38. France Viral Gene Therapy Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 39. U.K. Viral Gene Therapy Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 40. Italy Viral Gene Therapy Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 41. Russia Viral Gene Therapy Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 42. Asia Pacific Viral Gene Therapy Sales and Growth Rate (Kilotons)
Figure 43. Asia Pacific Viral Gene Therapy Sales Market Share by Region in 2023
Figure 44. China Viral Gene Therapy Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 45. Japan Viral Gene Therapy Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 46. South Korea Viral Gene Therapy Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 47. India Viral Gene Therapy Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 48. Southeast Asia Viral Gene Therapy Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 49. South America Viral Gene Therapy Sales and Growth Rate (Kilotons)
Figure 50. South America Viral Gene Therapy Sales Market Share by Country in 2023
Figure 51. Brazil Viral Gene Therapy Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 52. Argentina Viral Gene Therapy Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 53. Columbia Viral Gene Therapy Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 54. Middle East and Africa Viral Gene Therapy Sales and Growth Rate (Kilotons)
Figure 55. Middle East and Africa Viral Gene Therapy Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Viral Gene Therapy Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 57. UAE Viral Gene Therapy Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 58. Egypt Viral Gene Therapy Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 59. Nigeria Viral Gene Therapy Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 60. South Africa Viral Gene Therapy Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 61. Global Viral Gene Therapy Sales Forecast by Volume (2019-2030) & (Kilotons)
Figure 62. Global Viral Gene Therapy Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Viral Gene Therapy Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Viral Gene Therapy Market Share Forecast by Type (2025-2030)
Figure 65. Global Viral Gene Therapy Sales Forecast by Application (2025-2030)
Figure 66. Global Viral Gene Therapy Market Share Forecast by Application (2025-2030)
